Jingshuiliushen
Lv1
78 积分
2024-07-03 加入
-
An overview of the preclinical discovery and development of tezepelumab for the treatment of asthma
6天前
已完结
-
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
10天前
已完结
-
Investigational thymic stromal lymphopoietin inhibitors for the treatment of asthma: a systematic review
10天前
已完结
-
Type 2 severe asthma: pathophysiology and treatment with biologics
14天前
已完结
-
Rademikibart Treatment for Moderate-to-Severe, Uncontrolled Asthma: A Phase 2B Randomized Trial
14天前
已完结
-
Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, placebo-controlled, phase 4 trial
15天前
已完结
-
Development of a novel humanized anti-TSLP monoclonal antibody, QX008N, and exploration of combination therapy of anti-TSLP antibody and anti-IL-4R antibody
17天前
已完结
-
Thymic stromal lymphopoietin contributes to ozone-induced exacerbations of eosinophilic airway inflammation via granulocyte colony-stimulating factor in mice
17天前
已完结
-
Epithelial-Derived Cytokines in Asthma
17天前
已完结
-
Development of an inhaled anti-TSLP therapy for asthma
17天前
已完结